ライフサイエンスコーパス: bolus

1 ose of surfactant administered as a standard bolus.

2 of primary PCI compared with the intravenous bolus.

3 in the time from symptom onset to metoprolol bolus.

4 eceived no steroids after the intraoperative bolus.

5 t; 138 to sitagliptin-basal and 139 to basal-bolus.

6 fines of the bleb created by the intradermal bolus.

7 nuous intravenous infusion or as intravenous boluses.

8 The duration of contrast material bolus (0.5 mL/kg of body weight) was 3.8 seconds in the

9 f the opioid antagonist naloxone (0.15 mg/kg bolus + 0.1 mg/kg/h infusion) or saline placebo.

10 her a placebo (n = 7) or a lidocaine (n = 7) bolus (1.5 mg/kg), followed by continuous infusion (100

11 Bolus 23.4% hypertonic saline improves surveillance neur

12 by 94% among those who received an andexanet bolus (24 participants), as compared with 21% among thos

13 by 92% among those who received an andexanet bolus (27 participants), as compared with 18% among thos

14 not less likely to receive an adequate fluid bolus (30 mL/kg) by the time of hospital admission (p =

15 ived intraocular vancomycin via intracameral bolus (33/36), via intravitreal injection (1/36), or thr

16 m(2) intravenously over 2 h and fluorouracil bolus 400 mg/m(2) intravenously over 5 min, followed by

17 continuously infused dofetilide (6-9 mug/kg bolus+6-9 mug/kg per hour IV infusion) into anesthetized

18 ing a (67)Ga-, (111)In-, or (177)Lu-NeoBOMB1 bolus (74, 74, or 370 kBq, respectively, 100 muL, 10 pmo

19 ompared with those randomized to intravenous bolus (9.2% vs. 17.6%; hazard ratio [HR]: 0.49; 95% conf

20 irst, 3 subjects underwent studies comparing bolus administration and constant-infusion administratio

21 s infusion of doxorubicin is as effective as bolus administration in leukemia treatment, but no evide

22 period, (18)F-FDG PET imaging after a single bolus administration may underestimate the extent and de

23 ulation factors (historical control, n = 1), bolus administration of a human prothrombin concentrate

24 practical considerations, subcutaneous (SC) bolus administration of a solution formulation was selec

25 nfusion versus 23 +/- 14 s for intracoronary bolus administration of adenosine (P < 0.001).

26 lion 64, Japan) before and after intravenous bolus administration of iodinated non ionic contrast age

27 is (n = 107) that included intravenous fluid bolus administration with monitoring of jugular venous p

28 actant administration seems to be as safe as bolus administration, showing more stable cerebral hemod

29 After the bolus administration, the median anti-factor Xa activity

30 23.4% hypertonic saline bolus administration.

31 es lower than those required for intravenous bolus administration.

32 In-vivo MPI mouse images of a 512 ng bolus and a 21.5 ms acquisition time allow for capturing

33 using benzodiazepines and opioids, via both bolus and continuous infusion.

34 ensional DCE US imaging with two techniques (bolus and destruction-replenishment) was performed in hu

35 OX (folinic acid and oxaliplatin followed by bolus and infused fluorouracil).

36 IC), or FOLFOX (oxaliplatin, leucovorin, and bolus and infusional fluorouracil).

37 The initial bolus and ion current models give mathematically equival

38 descriptive preliminary analysis, an initial bolus and subsequent 2-hour infusion of andexanet substa

39 egative when (18)F-FDG was administered as a bolus and were always positive when it was administered

40 fects of administration of intravenous fluid boluses and vasopressors in patients with sepsis across

41 mug/kg/d) or terlipressin (single 2-mg i.v. bolus), and the regional hemodynamic effects were quanti

42 jection, MicronJet administration of a 50muL bolus appears to create multiple superficial microdisrup

43 constant-infusion scan matched that from the bolus application (test-retest variability, 1.1% +/- 24.

44 Sedation by IV propofol bolus application delayed after controlled cortical impa

45 ase of SDF-1 from PPCN (PPCN+SDF-1) versus a bolus application of SDF-1 in phosphate buffered saline

46 uantified from a 60-min scan after (18)F-FDG bolus application using the Patlak plot (eyes closed).

47 parate bursts, mimicking the delivery of two boluses approximately one month apart.

48 The distribution heterogeneity of bolus arrival time (P = .029), time to peak (P = .008),

49 exposure applied chronically, or as a single bolus at postnatal day 1, markedly worsened AAA outcomes

50 in seconds and results in a concentrated DNA bolus at the capillary orifice.

51 ed to intracoronary or intravenous abciximab bolus at the time of primary PCI.

52 d first-pass perfusion (0.03 mmol/kg Gd-DTPA bolus) at stress and rest (4-6 minutes IV adenosine, 140

53 Dexrazoxane was given as an intravenous bolus before each doxorubicin dose.

54 uggests that an intravenous or intestinal Pi bolus causes rapid phosphaturia through mechanisms requi

55 Three-station bolus-chase MR angiography with real-time fluoroscopic t

56 tected) was significantly longer than median bolus clearance time (impedance-detected) in the total [

57 clearance time (pH-detected) and the median bolus clearance time (impedance-detected) was significan

58 body and cytotoxic T-cell levels compared to bolus controls.

59 e, in 20 of 38 (53%) patients, FDG PET/split-bolus CT allowed detection of important additional findi

60 were concordant and detected with both split-bolus CT and PET/unenhanced CT, 16 with split-bolus CT o

61 the independently acquired FDG PET and split-bolus CT data, and fused datasets were compared with FDG

62 olus CT and PET/unenhanced CT, 16 with split-bolus CT only, and two with PET/unenhanced CT.

63 The split-bolus CT protocol included imaging during the hepatic ar

64 ntified with PET/unenhanced CT and PET/split-bolus CT.

65 ons were identified with fused FDG PET/split-bolus CT; 41 were concordant and detected with both spli

66 ed US with VEGFR2-targeted microbubbles, (b) bolus DCE US with nontargeted microbubbles, and (c) dest

67 The intracoronary abciximab bolus did not reduce the primary endpoint in patients wi

68 odeling or the Patlak approach, even without bolus dispersion correction or blood sampling, with an u

69 Correction for tracer bolus dispersion in blood between the vena cava and the

70 Single bolus dose and 28-days of repeated administration of DMA

71 blood pressure (-3.5 mm Hg), and mean daily bolus dose of insulin (-2.8 units per day) (P</=0.002 fo

72 ght, systolic blood pressure, and mean daily bolus dose of insulin.

73 lar to replicating infections, rather than a bolus dose.

74 operidol titration: all patients received IV bolus doses of haloperidol until agitation was controlle

75 Bolus dosing of fentanyl and midazolam fails to reduce t

76 tumor burden to the same extent as weekly IP bolus drug injections.

77 Administration of an intracoronary abciximab bolus during primary percutaneous coronary intervention

78 f during high tide, and then release it in a bolus during the falling tide when drainpipe outlets are

79 andomized children) vs low-dose UFH (50 U/kg bolus) during cardiac catheterization in children.

80 nesiritide (0.005 mug/kg per minute without bolus) enhanced decongestion or preserved renal function

81 o weeks, whereas nonlive vaccines are single bolus events.

82 ntration although this fall was greater with bolus feeding (P < 0.0001).

83 n increase in small bowel water content with bolus feeding after 90 minutes (P < 0.0068).

84 Bolus feeding also led to an increase in concentrations

85 ed to limit peak dead-time losses during the bolus first-pass transit.

86 entration were significantly decreased after bolus fluid administration.

87 eceived postoperative chemoradiotherapy with bolus fluorouracil (FU) and leucovorin (LV) compared wit

88 r, oxaliplatin 85 mg/m(2) in a 2-h infusion, bolus fluorouracil 400 mg/m(2) on day 1, and a 46-h infu

89 can 180 mg/m(2), leucovorin 400 mg/m(2), and bolus fluorouracil 400 mg/m(2), followed by 2400 mg/m(2)

90 in 350 mg infusion over 2 h, and 400 mg/m(2) bolus fluorouracil followed by a 2400 mg/m(2) continuous

91 over 2 h, 200 mg leucovorin, and 400 mg/m(2) bolus fluorouracil followed by a 2400 mg/m(2) continuous

92 an plus oxaliplatin] and IFL [irinotecan and bolus fluorouracil plus leucovorin]).

93 at 140 mg/m(2), and fluorouracil 400 mg/m(2) bolus followed by 2400 mg/m(2) over 46 h).

94 ntrolled trial comparing high-dose (100 U/kg bolus followed by age-based continuous infusion in rando

95 ioligand [(11)C]AZ10419369 administered as a bolus followed by constant infusion to measure changes i

96 We find that three models-an initial bolus formation model, an ion current model, and a diffu

97 XELOX improved OS compared with bolus FU/FA in patients with resected stage III colon ca

98 wice daily on days 1 to 14 every 3 weeks, or bolus FU/FA, as the Mayo Clinic or Roswell Park regimens

99 After an oral lipid bolus, Gpat3(-/-) mice exhibited attenuated plasma TG ex

100 wo before randomisation and one in the basal-bolus group (due to severe acute myocardial infarction a

101 tin-basal group and in 17 (12%) in the basal-bolus group (p=0.45).

102 tin-basal group versus 26 (19%) in the basal-bolus group (p=0.54).

103 rred in the stepwise group than in the basal-bolus group (rate ratio 0.58 [95% CI 0.45 to 0.75]; p<0.

104 2.7]) was not inferior to that in the basal-bolus group 9.4 mmol/L [2.7]) with a mean blood glucose

105 Patients in the basal-bolus group received insulin aspart before every meal th

106 lin lispro or aspart before meals (the basal-bolus group) during the hospital stay.

107 ) developed acute pancreatitis (in the basal-bolus group).

108 liptin-basal group and six (4%) in the basal-bolus group.

109 1 ratio to either REG1 (pegnivacogin 1 mg/kg bolus [>99% factor IXa inhibition] followed by 80% rever

110 esults suggest that protein synthesis during bolus H2O2 stress does not affect clearance dynamics and

111 ore complete phenotypic rescue than a single bolus high-dose injection at PND0.

112 ons compared with the historical control and bolus hPCC recipients.

113 contrast, platelet levels were maintained in bolus hPCC recipients; however, these animals quickly de

114 We investigated the hypothesis that bolus hypertonic saline decreases cerebral edema in seve

115 d only few clinical cases of esophageal food bolus impaction due to esophageal motility disorders.

116 st time a case of 53-year-old male with food bolus impaction due to Jackhammer esophagus referred to

117 in the selected patients with food boneless bolus impaction in the emergency settings.

118 the following factors regarding the outcome 'bolus impaction' by univariate logistic regression model

119 itial diagnosis or recrudescence (i.e., food bolus impaction) of EoE.

120 variation in diagnosis or incidence of food bolus impaction.

121 g factors were significantly associated with bolus impaction: swallowed topical corticosteroid therap

122 nificantly reduces the risk for long-lasting bolus impactions.

123 teroids was associated with a lower risk for bolus impactions.

124 n donor plasma was infused as an intravenous bolus in 7 healthy adult human volunteers at </=2 mg/kg

125 d 1 hour after administration of an IV fluid bolus in the emergency department.

126 uous intravenous infusion versus intravenous boluses in the treatment of type 1 HRS.

127 nfusion is better tolerated than intravenous boluses in the treatment of type 1 HRS.

128 rhIL-15) administered as a daily intravenous bolus infusion for 12 consecutive days in patients with

129 tment with or without dexrazoxane given as a bolus infusion immediately before every dose of doxorubi

130 gh insufficient evidence supports its use in bolus, infusional, or combination FU.

131 low-up of 9.5 years, 10-year OS rates in the bolus/infusional fluorouracil plus leucovorin (LV5FU2) a

132 Bolus infusions of 3.0, 1.0, and 0.3 mug/kg per day of I

133 affective and sensory experiences following bolus infusions of either isoproterenol, a rapidly actin

134 Bolus infusions of saline and isoproterenol (1 or 2 mug)

135 es postorder; and 4) 30 mL/kg IV crystalloid bolus initiated less than or equal to 30 minutes from "t

136 Atropine bolus injection (0.04 mg/kg) did not increase heart rate

137 urements were performed during intracoronary bolus injection (40 mug for the right and 80 mug for the

138 F-D4-FCH was intravenously administered as a bolus injection (mean +/- SD, 161 +/- 2.17 MBq; range, 1

139 to receive doxorubicin alone (75 mg/m(2) via bolus injection administered over 5-20 min or continuous

140 At 120 min after bolus injection and after the start of radiotracer infus

141 humoral immune response compared to a single bolus injection and was statistically non-inferior from

142 array of micropores in the skin, instead of bolus injection at a single site.

143 Duration of contrast material bolus injection does not influence CT perfusion values s

144 otency and duration of action on intravenous bolus injection in diabetic rats are indistinguishable f

145 T scans at 0, 15, 90, 120, and 180 min after bolus injection of (123)I-mIBG on a hybrid cadmium zinc

146 in list mode started simultaneously with the bolus injection of (123)I-MIBG, and data were collected

147 m-diethylenetriaminepentaacetic acid (DTPA), bolus injection of (18)F-FDG, bolus injection of (99)Tc-

148 maging 0-120, 150-180, and 210-240 min after bolus injection of (18)F-FEOBV.

149 t scans were started just before intravenous bolus injection of (18)F-LMI1195.

150 dynamic PET imaging for up to 120 min after bolus injection of (18)F-T807 with arterial blood sampli

151 dynamic PET imaging for up to 120 min after bolus injection of (18)F-T807 with arterial blood sampli

152 c acid (DTPA), bolus injection of (18)F-FDG, bolus injection of (99)Tc-DTPA to simulate the distribut

153 Patients received a bolus injection of 0.2 mL of contrast material for quali

154 nderwent a dynamic PET scanning session with bolus injection of [(11)C]DAA1106 (with smokers in the s

155 Intracoronary bolus injection of adenosine (40 mug for the right and 8

156 By contrast, acute ICV bolus injection of chemerin on a 12 h:12 h photoperiod i

157 of the culprit coronary artery to receive a bolus injection of cyclosporine (administered intravenou

158 Patients received an intravenous bolus injection of cyclosporine, 2.5 mg/kg, at the onset

159 d after infarction with PET/MR imaging after bolus injection of gadolinium-diethylenetriaminepentaace

160 h underwent two MR imaging examinations with bolus injection of gadoxetate disodium at one of two sit

161 s were acquired before and dynamically after bolus injection of gadoxetate disodium, normal saline, a

162 bition of activated factor XII with a single bolus injection of recombinant human albumin-fused infes

163 nd (ii) with transient changes in BP using a bolus injection of SNP (ARISNP ) and PhE (ARIPhE ).

164 After intravenous bolus injection, (18)F-MNI-444 rapidly entered the brain

165 d for 90 min immediately after [(11)C]ABP688 bolus injection.

166 sion seems to yield more robust results than bolus injection.

167 us infusion for 2 weeks compared to a single bolus injection.

168 Bolus injections of microbubbles at 4 muL/kg were tested

169 Based on our data, bolus injections seem to be required in order to achieve

170 and was statistically non-inferior from two bolus injections spaced 1 month apart.

171 h the microdevice vs. 2118 ng-day/mL with IP bolus injections).

172 ulted in significantly less toxicity than IP bolus injections, despite administration of higher cumul

173 caemia when compared to multiple daily basal-bolus injections.

174 us insulin), 2) hyperinsulinemic euglycemia (bolus insulin and glucose infusion), and 3) saline contr

175 t alternative to, the labour-intensive basal-bolus insulin regimen for the management of hyperglycaem

176 sitagliptin) plus basal insulin with a basal-bolus insulin regimen for the management of patients wit

177 onal insulin treatment, advancing to a basal-bolus insulin regimen is often recommended.

178 was non-inferiority of stepwise addition of bolus insulin versus complete basal-bolus therapy, as as

179 tudy days: 1) hyperinsulinemic hypoglycemia (bolus insulin), 2) hyperinsulinemic euglycemia (bolus in

180 bsorp) and hormone secretion after a glucose bolus into the distal jejunum.

181 Intravenous glyburide was given as a 0.13 mg bolus intravenous injection for the first 2 min, followe

182 The goal of this initial bolus is to quickly treat cerebral edema.

183 osed-loop insulin delivery without meal-time boluses is effective and safe in insulin-treated adults

184 osed-loop insulin delivery without meal-time boluses is effective and safe in insulin-treated adults

185 Infarction) trial, a single intravenous CsA bolus just before primary percutaneous coronary interven

186 Pulmonary blood flow (PBF), first-pass bolus kinetic parameters, and biventricular mass and fun

187 pk reduced the glucose-lowering effects of a bolus metformin treatment in rat models of diabetes.

188 tobleaching experiments rule out the initial bolus model, suggesting that either the ion current mode

189 DG PET/unenhanced multidetector CT and split-bolus multidetector CT for restaging were investigated r

190 Fused FDG PET/split-bolus multidetector CT provides additional information c

191 Bolus nasogastric feeding led to significant elevations

192 d to demonstrate the effect of continuous or bolus nasogastric feeding on gastric emptying, small bow

193 ta were acquired during 50 min after a 1-min bolus of (18)F-FET.

194 randomized to receive either an intravenous bolus of 0.5 mg/kg per 12 hours of methylprednisolone (n

195 athy exhibiting neurologic manifestations, a bolus of 100 mL of 3% saline, given over 10 minutes, sho

196 (18)F-UCB-H was injected intravenously (bolus of 140 +/- 20 MBq).

197 After a 4-h "basal" period, a 21-g bolus of amino acids was administered and a 3-h hyperins

198 The patients all received a bolus of andexanet followed by a 2-hour infusion of the

199 All patients received MMF plus a bolus of corticosteroid (no maintenance steroids).

200 stigated the effects of an acute intravenous bolus of DHA delivered after SCI and characterized DHA-i

201 r an uncoated fiber in response to a 1.0 muM bolus of dopamine.

202 A 1-MBq bolus of each candidate tracer (and (18)F-fluoromisonida

203 We postulated that a bolus of enhanced IL-21-primed polyclonal antigen-specif

204 This one bolus of fat resulted in a measurable increase in insuli

205 Rats received a single intraperitoneal bolus of glucose, glycerol, and lactate under a fed or f

206 sion of a Gd-based Zn(II) sensor and an i.p. bolus of glucose.

207 guidelines adopted the approach of giving a bolus of hypertonic saline.

208 in-converting enzyme inhibitors and a single bolus of icatibant (HOE-140) immediately before anesthes

209 rapidly reached and sustained with a single bolus of icatibant.

210 ), and 5) shocked mice treated with a single bolus of icatibant.

211 us, basiliximab, mycophenolate mofetil and 1 bolus of intraoperative corticosteroids (0-1000 mg) as p

212 ibiotics and to the completion of an initial bolus of intravenous fluid.

213 but not a longer time to the completion of a bolus of intravenous fluids (odds ratio, 1.01 per hour;

214 tics, but not rapid completion of an initial bolus of intravenous fluids, were associated with lower

215 e retinal pigment epithelium (RPE) ingests a bolus of lipid and protein in the form of phagocytized p

216 as measured by monitoring the depletion of a bolus of nitric oxide injected into anoxic cultures with

217 lk endocytosis in neurons, which retrieves a bolus of plasma membrane deposited by synaptic vesicle f

218 ive an MRA regimen with a single intravenous bolus of potassium canrenoate (200 mg) followed by oral

219 cretion of these proteins, indicating that a bolus of secretion of colonization and virulence factors

220 of an outer envelope, an inner matrix, and a bolus of sperm.

221 were blindly, block randomized to receive IV boluses of normal saline (control) and doxycycline at 5

222 the initial dose of 2 mg/day or intravenous boluses of terlipressin (TERLI-BOL group) at the initial

223 ither doxorubicin (75 mg/m(2) by intravenous bolus on day 1 or 72 h continuous intravenous infusion)

224 ation was mimicked by an intravenous insulin bolus on placebo day.

225 lus versus those receiving an intraoperative bolus only.

226 cted to evaluate andexanet administered as a bolus or as a bolus plus a 2-hour infusion.

227 ib (1.3 mg/m(2)) was given as an intravenous bolus or subcutaneous injection on days 1, 4, 8, and 11

228 ion) or bortezomib (1.3 mg/m(2); intravenous bolus or subcutaneous injection) and dexamethasone (20 m

229 re randomized 1:1 to IV metoprolol (2 x 5-mg bolus) or matched placebo before PPCI.

230 ned (1:1) to ketamine (0.5 mg/kg intravenous bolus) or saline adjunctive to the anaesthetic for the d

231 g insulin analogue without meal-time insulin boluses) or conventional subcutaneous insulin delivery a

232 material injected intravenously as a single bolus; or protocol B, 100 mL of contrast material inject

233 s were randomly assigned to receive either a bolus oral dose of 100,000 IU cholecalciferol followed b

234 ived 400 mL of Resource Energy (Nestle) as a bolus over 5 minutes or continuously over 4 hours via pu

235 te andexanet administered as a bolus or as a bolus plus a 2-hour infusion.

236 stained when andexanet was administered as a bolus plus an infusion.

237 s 47 hospitals and treated with eptifibatide bolus plus infusion with those treated with a catheteriz

238 he optimally matched analysis, compared with bolus plus infusion, a catheterization laboratory-only r

239 s, whereas 16 785 patients were treated with bolus plus infusion.

240 hibitor, is conventionally administered as a bolus plus infusion.

241 ts, the radiotracer was administered using a bolus-plus-infusion protocol, the arterial input functio

242 ce (18 h before scanning), using a validated bolus-plus-infusion protocol.

243 vestigated the use of intravenous (IV) fluid bolus prior to lumbar puncture.

244 investigates the influence of delayed single-bolus propofol applications at the peak of p75 neurotrop

245 ily (the sitagliptin-basal group) or a basal-bolus regimen with glargine once daily and rapid-acting

246 of a stepwise dosing approach versus a basal-bolus regimen.

247 perienced 42 impactions requiring endoscopic bolus removal.

248 In mice, the saturated fat bolus resulted in the induction of several NAFLD-associa

249 l pressure initially decreased further under bolus resuscitation (-10 mm Hg; p < 0.001) and was lower

250 n (-10 mm Hg; p < 0.001) and was lower under bolus resuscitation than closed loop at 20 minutes (bolu

251 In comparison with formula-based bolus resuscitation, both semiautonomous and autonomous

252 on systems and compare them to formula-based bolus resuscitation.

253 loop and were significantly increased under bolus resuscitation.

254 0.001), plasma volume, extravascular volume (bolus resuscitation: 17 +/- 4 mL/kg, decision assist: 3

255 Colloid osmotic pressure (bolus resuscitation: 19.3 +/- 2 mm Hg, decision assist,

256 morrhage, the total amount of infused fluid (bolus resuscitation: 30 mL/kg, decision assist: 5.6 +/-

257 esuscitation than closed loop at 20 minutes (bolus resuscitation: 57 +/- 2 mm Hg, closed loop: 69 +/-

258 n scheme on separate visits 1) formula-based bolus resuscitation; 2) semiautonomous (decision assist)

259 fusion values (in minutes(-1)) for the short bolus series were 1.95 and 2.03, respectively (P = .22),

260 ) was 3.8 seconds in the first series (short bolus series) and 11.5 seconds in the second series (lon

261 and 11.5 seconds in the second series (long bolus series), and the injection flow rate was adapted a

262 03, respectively (P = .22), and for the long bolus series, they were 2.02 and 1.92, respectively (P =

263 If signs persist, the bolus should be repeated in order to achieve clinical re

264 Two water-bolus sizes (5 and 10 mL) were tested in random order.

265 Two water bolus sizes (5 and 10 mL) were tested in random order.

266 e the cerebral effects of aerosolized versus bolus surfactant administration in premature lambs with

267 ate of oxygen increased significantly in the bolus surfactant group during the first 5 minutes, witho

268 t was not significantly different to that of bolus surfactant in terms of cerebral necrosis, edema, i

269 m brainstem regions) remaining higher in the bolus surfactant than in the aerosolized surfactant grou

270 eive intratracheal aerosolized surfactant or bolus surfactant.

271 story as well as the absence of bones in the bolus, the patient was submitted to a new conservative t

272 ition of bolus insulin versus complete basal-bolus therapy, as assessed by change in HbA1c from basel

273 ) has acceptable agreement with intermittent bolus thermodilution over a wide range of cardiac output

274 surement and a pulmonary artery catheter for bolus thermodilution.

275 ics and an intravenous palmitate radiotracer bolus/timed biopsy.

276 he dendribodies were administered in an i.v. bolus to male Sprague Dawley rats after starting a s.c.

277 olol), the median time from 15 mg metoprolol bolus to reperfusion was 53 min.

278 lit by the median time from 15 mg metoprolol bolus to reperfusion.

279 apy having either a long or short metoprolol bolus-to-reperfusion interval.

280 lts The dual-energy CT protocol consisted of bolus tracking in the abdominal aorta (threshold, 150 HU

281 motility as determined by in vivo intestinal bolus tracking.

282 ve-layer wall, and peristaltic motility with bolus transit.

283 eive either stepwise treatment or full basal-bolus treatment.

284 cquisition by using the descending aorta for bolus triggering can improve the enhancement of the pulm

285 As standard bolus triggering in the pulmonary trunk sometimes fails

286 Bolus triggering with 120 hounsfield units (HU) was perf

287 increases in antibody production relative to bolus vaccination post prime.

288 For bolus versus infusion, E* values were always negative wh

289 0 days plus an intraoperative corticosteroid bolus versus those receiving an intraoperative bolus onl

290 INTERPRETATION: High-dose bolus vitamin D supplementation of 100 000 IU colecalcif

291 d the median time to completion of the fluid bolus was 2.56 hours (interquartile range, 1.33 to 4.20)

292 hnoid space before and 1 hour after IV fluid bolus was 37.8 (11.1) mm(2) and 36.9 (11.2) mm(2) respec

293 ation to the administration of the andexanet bolus was 4.8+/-1.8 hours.

294 , intracoronary versus intravenous abciximab bolus was associated with a significantly reduced risk o

295 o 6 mL/kg predicted body weight, and a fluid bolus was given to identify fluid responders (increase i

296 iodine concentration, the mean iodixanol 270 bolus was larger compared with that of iopromide 300 (76

297 ize distributions (PSDs) of the expectorated boluses were measured by using mechanical sieving and la

298 Intravenous fluid boluses were not associated with a significant increase

299 pplied to the skin, deliver ATRA as a single bolus, which is immediately taken up into the skin and c

300 ulin delivery was calculated with a standard bolus wizard.